Insights

Where would you like to start?

Discover how we work. Or read our latest issue.

This is why

One issue tells you everything.

Here's a recent edition in full, on what's actually happening with AI in pharma. This is the kind of thing that lands in your inbox every week. Read it, then decide.

Latest issue · AI in pharma Pharma leaders reviewing AI strategy
Ben Woollard8 min readApr 2026

You can't AI your way out of a broken operating model.

Why pharma's AI frenzy is more expensive than it looks, and the four moves that separate leaders who'll get real value from those left with expensive tools gathering dust.

9% of life sciences executives report significant returns on AI so far, while 78% expect major change in 2026.
Read the full issue
Every week

Verified analysis

What's really moving in pharma leadership, checked against primary sources, never recycled from LinkedIn.

Frameworks

Models you can use Monday

Practical tools like the four levels of AI maturity, built to be applied to your team, not admired.

Secret Diary of a VP

The honest version

What senior leaders actually think, and the mistakes they'd only admit anonymously.

Start with the read. Stay for the work.

Subscribe to the free weekly briefing, or book a 15-minute conversation about what we could surface inside your team.

A 15-minute call, with no pitch and no obligation. You'll leave with at least one useful insight, whether we work together or not.